Trial Profile
Fluoxetine and Divalproex: Treatment Correlates in Intermittent Explosive Disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Apr 2021
Price :
$35
*
At a glance
- Drugs Fluoxetine (Primary) ; Valproate semisodium (Primary)
- Indications Impulse control disorders
- Focus Therapeutic Use
- 11 Dec 2008 New trial record.